Salt-Responsive Metabolite, β-Hydroxybutyrate, Attenuates Hypertension

Cell Reports

Volumn 25, Issue 3, 2018, Pages 677-689.e4

  Chakraborty, Saroj ^a   Galla, Sarah ^a   Cheng, Xi ^a   Yeo, Ji Youn ^a   Mell, Blair ^a   Singh, Vishal ^a   Yeoh, BengSan ^a   Saha, Piu ^a   Mathew, Anna V ^b   Vijay Kumar, Matam ^a   Joe, Bina ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

blood pressure; hypertension; inflammasome; inflammation; ketone body; kidney; metabolomics; Nlrp3; salt; hydroxybutyrate

Indexed keywords

3 HYDROXYBUTYRIC ACID; CRYOPYRIN; INFLAMMASOME; KETONE BODY; FLAVORING AGENT; NLRP3 PROTEIN, RAT;

ARTICLE; CONTROLLED STUDY; DAHL SALT SENSITIVE RAT; DIET SUPPLEMENTATION; EXERCISE; HUMAN; HYPERTENSION; INTESTINE FLORA; KIDNEY FUNCTION; LIFESTYLE MODIFICATION; METABOLIC SYNDROME X; METABOLITE; METABOLOMICS; PRIORITY JOURNAL; SALT INTAKE; TH17 CELL; ANIMAL; BLOOD PRESSURE; DAHL RAT; DRUG EFFECT; IMMUNOLOGY; MALE; METABOLISM; METABOLOME; RAT; TOXICITY;

3-HYDROXYBUTYRIC ACID; ANIMALS; BLOOD PRESSURE; FLAVORING AGENTS; GASTROINTESTINAL MICROBIOME; HYPERTENSION; INFLAMMASOMES; MALE; METABOLOME; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; RATS; RATS, INBRED DAHL; SODIUM CHLORIDE, DIETARY;

EID: 85054711695     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2018.09.058     Document Type: Article

References (86)

1. Abubucker, S., Segata, N., Goll, J., Schubert, A.M., Izard, J., Cantarel, B.L., Rodriguez-Mueller, B., Zucker, J., Thiagarajan, M., Henrissat, B., et al. Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol., 8, 2012, e1002358.
2. Anders, H.J., Suarez-Alvarez, B., Grigorescu, M., Foresto-Neto, O., Steiger, S., Desai, J., Marschner, J.A., Honarpisheh, M., Shi, C., Jordan, J., et al. The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury. Kidney Int. 93 (2018), 656–669.
3. Arima, S., Uto, H., Ibusuki, R., Kumamoto, R., Tanoue, S., Mawatari, S., Oda, K., Numata, M., Fujita, H., Oketani, M., et al. Hypertension exacerbates liver injury and hepatic fibrosis induced by a choline-deficient L-amino acid-defined diet in rats. Int. J. Mol. Med. 33 (2014), 68–76.
4. Bai, M., Chen, Y., Zhao, M., Zhang, Y., He, J.C., Huang, S., Jia, Z., Zhang, A., NLRP3 inflammasome activation contributes to aldosterone-induced podocyte injury. Am. J. Physiol. Renal Physiol. 312 (2017), F556–F564.
5. Barbato, J.C., Koch, L.G., Darvish, A., Cicila, G.T., Metting, P.J., Britton, S.L., Spectrum of aerobic endurance running performance in eleven inbred strains of rats. J. Appl. Physiol. (1985) 85 (1998), 530–536.
6. Bomfim, G.F., Rodrigues, F.L., Carneiro, F.S., Are the innate and adaptive immune systems setting hypertension on fire?. Pharmacol. Res. 117 (2017), 377–393.
7. Brown, I.J., Tzoulaki, I., Candeias, V., Elliott, P., Salt intakes around the world: implications for public health. Int. J. Epidemiol. 38 (2009), 791–813.
8. Bugyei-Twum, A., Abadeh, A., Thai, K., Zhang, Y., Mitchell, M., Kabir, G., Connelly, K.A., Suppression of NLRP3 inflammasome activation ameliorates chronic kidney disease-induced cardiac fibrosis and diastolic dysfunction. Sci. Rep., 6, 2016, 39551.
9. Caporaso, J.G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F.D., Costello, E.K., Fierer, N., Peña, A.G., Goodrich, J.K., Gordon, J.I., et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7 (2010), 335–336.
10. Carpenter, R.G., Grossman, S.P., Plasma fat metabolites and hunger. Physiol. Behav. 30 (1983), 57–63.
11. Collado, M.C., Isolauri, E., Laitinen, K., Salminen, S., Distinct composition of gut microbiota during pregnancy in overweight and normal-weight women. Am. J. Clin. Nutr. 88 (2008), 894–899.
12. Cox, P.J., Kirk, T., Ashmore, T., Willerton, K., Evans, R., Smith, A., Murray, A.J., Stubbs, B., West, J., McLure, S.W., et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 24 (2016), 256–268.
13. Dahl, L.K., Effects of chronic excess salt feeding. Induction of self-sustaining hypertension in rats. J. Exp. Med. 114 (1961), 231–236.
14. Dahl, L.K., Heine, M., Tassinari, L., Effects of chronic excess salt ingestion. vascular reactivity in two strains of rats with opposite genetic susceptibility to experimental hypertension. Circulation 30:Suppl 2 (1964), 11–22.
15. Dahl, L.K., Knudsen, K.D., Iwai, J., Genetic influence of the kidney in hypertension-prone rats. Circ. Res., 27(Suppl 2), 1970, 277.
16. De Miguel, C., Das, S., Lund, H., Mattson, D.L., T lymphocytes mediate hypertension and kidney damage in Dahl salt-sensitive rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298 (2010), R1136–R1142.
17. De Miguel, C., Rudemiller, N.P., Abais, J.M., Mattson, D.L., Inflammation and hypertension: new understandings and potential therapeutic targets. Curr. Hypertens. Rep., 17, 2015, 507.
18. DeSantis, T.Z., Hugenholtz, P., Larsen, N., Rojas, M., Brodie, E.L., Keller, K., Huber, T., Dalevi, D., Hu, P., Andersen, G.L., Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72 (2006), 5069–5072.
19. Dolinsky, V.W., Morton, J.S., Oka, T., Robillard-Frayne, I., Bagdan, M., Lopaschuk, G.D., Des Rosiers, C., Walsh, K., Davidge, S.T., Dyck, J.R., Calorie restriction prevents hypertension and cardiac hypertrophy in the spontaneously hypertensive rat. Hypertension 56 (2010), 412–421.
20. Edgar, R.C., Search and clustering orders of magnitude faster than BLAST. Bioinformatics 26 (2010), 2460–2461.
21. Evans, M., Cogan, K.E., Egan, B., Metabolism of ketone bodies during exercise and training: physiological basis for exogenous supplementation. J. Physiol. 595 (2017), 2857–2871.
22. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., Guiot, Y., Derrien, M., Muccioli, G.G., Delzenne, N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110 (2013), 9066–9071.
23. Feldman, N., Rotter-Maskowitz, A., Okun, E., DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res. Rev. 24:Pt A (2015), 29–39.
24. Foresto-Neto, O., Ávila, V.F., Arias, S.C.A., Zambom, F.F.F., Rempel, L.C.T., Faustino, V.D., Machado, F.G., Malheiros, D.M.A.C., Abensur, H., Camara, N.O.S., et al. NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model. Lab. Invest. 98 (2018), 773–782.
25. Garrett, M.R., Dene, H., Rapp, J.P., Time-course genetic analysis of albuminuria in Dahl salt-sensitive rats on low-salt diet. J. Am. Soc. Nephrol. 14 (2003), 1175–1187.
26. Garrett, M.R., Joe, B., Yerga-Woolwine, S., Genetic linkage of urinary albumin excretion in Dahl salt-sensitive rats: influence of dietary salt and confirmation using congenic strains. Physiol. Genomics 25 (2006), 39–49.
27. Greene, A.S., Yu, Z.Y., Roman, R.J., Cowley, A.W. Jr., Role of blood volume expansion in Dahl rat model of hypertension. Am. J. Physiol. 258 (1990), H508–H514.
28. Ha, V., Sievenpiper, J.L., de Souza, R.J., Chiavaroli, L., Wang, D.D., Cozma, A.I., Mirrahimi, A., Yu, M.E., Carleton, A.J., Dibuono, M., et al. Effect of fructose on blood pressure: a systematic review and meta-analysis of controlled feeding trials. Hypertension 59 (2012), 787–795.
29. Hall, S.E., Wastney, M.E., Bolton, T.M., Braaten, J.T., Berman, M., Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation. J. Lipid Res. 25 (1984), 1184–1194.
30. Han, J., Lin, K., Sequeira, C., Borchers, C.H., An isotope-labeled chemical derivatization method for the quantitation of short-chain fatty acids in human feces by liquid chromatography-tandem mass spectrometry. Anal. Chim. Acta 854 (2015), 86–94.
31. Hattori, T., Murase, T., Takatsu, M., Nagasawa, K., Matsuura, N., Watanabe, S., Murohara, T., Nagata, K., Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome. J. Am. Heart Assoc., 3, 2014, e001312.
32. Huang, B., Cheng, Y., Usa, K., Liu, Y., Baker, M.A., Mattson, D.L., He, Y., Wang, N., Liang, M., Renal Tumor Necrosis Factor α Contributes to Hypertension in Dahl Salt-Sensitive Rats. Sci. Rep., 6, 2016, 21960.
33. Hutton, H.L., Ooi, J.D., Holdsworth, S.R., Kitching, A.R., The NLRP3 inflammasome in kidney disease and autoimmunity. Nephrology (Carlton) 21 (2016), 736–744.
34. Karlsson, C.L., Onnerfält, J., Xu, J., Molin, G., Ahrné, S., Thorngren-Jerneck, K., The microbiota of the gut in preschool children with normal and excessive body weight. Obesity (Silver Spring) 20 (2012), 2257–2261.
35. Kersse, K., Bertrand, M.J., Lamkanfi, M., Vandenabeele, P., NOD-like receptors and the innate immune system: coping with danger, damage and death. Cytokine Growth Factor Rev. 22 (2011), 257–276.
36. Kimura, T., Hashimoto, Y., Tanaka, M., Asano, M., Yamazaki, M., Oda, Y., Toda, H., Marunaka, Y., Nakamura, N., Fukui, M., Sodium-chloride difference and metabolic syndrome: a population-based large-scale cohort study. Intern. Med. 55 (2016), 3085–3090.
37. Kitada, K., Daub, S., Zhang, Y., Klein, J.D., Nakano, D., Pedchenko, T., Lantier, L., LaRocque, L.M., Marton, A., Neubert, P., et al. High salt intake reprioritizes osmolyte and energy metabolism for body fluid conservation. J. Clin. Invest. 127 (2017), 1944–1959.
38. Kumarasamy, S., Gopalakrishnan, K., Abdul-Majeed, S., Partow-Navid, R., Farms, P., Joe, B., Construction of two novel reciprocal conplastic rat strains and characterization of cardiac mitochondria. Am. J. Physiol. Heart Circ. Physiol. 304 (2013), H22–H32.
39. Lanaspa, M.A., Kuwabara, M., Andres-Hernando, A., Li, N., Cicerchi, C., Jensen, T., Orlicky, D.J., Roncal-Jimenez, C.A., Ishimoto, T., Nakagawa, T., et al. High salt intake causes leptin resistance and obesity in mice by stimulating endogenous fructose production and metabolism. Proc. Natl. Acad. Sci. USA 115 (2018), 3138–3143.
40. Langille, M.G., Zaneveld, J., Caporaso, J.G., McDonald, D., Knights, D., Reyes, J.A., Clemente, J.C., Burkepile, D.E., Vega Thurber, R.L., Knight, R., et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat. Biotechnol. 31 (2013), 814–821.
41. Lemos, D.R., McMurdo, M., Karaca, G., Wilflingseder, J., Leaf, I.A., Gupta, N., Miyoshi, T., Susa, K., Johnson, B.G., Soliman, K., et al. Interleukin-1β activates a MYC-dependent metabolic switch in kidney stromal cells necessary for progressive tubulointerstitial fibrosis. J. Am. Soc. Nephrol. 29 (2018), 1690–1705.
42. Livak, K.J., Schmittgen, T.D., Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 (2001), 402–408.
43. Maalouf, M., Rho, J.M., Mattson, M.P., The neuroprotective properties of calorie restriction, the ketogenic diet, and ketone bodies. Brain Res. Brain Res. Rev. 59 (2009), 293–315.
44. Mahoney, L.B., Denny, C.A., Seyfried, T.N., Caloric restriction in C57BL/6J mice mimics therapeutic fasting in humans. Lipids Health Dis., 5, 2006, 13.
45. Mattson, D.L., Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury. Am. J. Physiol. Renal Physiol. 307 (2014), F499–F508.
46. Mattson, D.L., James, L., Berdan, E.A., Meister, C.J., Immune suppression attenuates hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 48 (2006), 149–156.
47. Mell, B., Jala, V.R., Mathew, A.V., Byun, J., Waghulde, H., Zhang, Y., Haribabu, B., Vijay-Kumar, M., Pennathur, S., Joe, B., Evidence for a link between gut microbiota and hypertension in the Dahl rat. Physiol. Genomics 47 (2015), 187–197.
48. Melo, D.S., Costa-Pereira, L.V., Santos, C.S., Mendes, B.F., Costa, K.B., Santos, C.F., Rocha-Vieira, E., Magalhães, F.C., Esteves, E.A., Ferreira, A.J., et al. Severe calorie restriction reduces cardiometabolic risk factors and protects rat hearts from ischemia/reperfusion injury. Front. Physiol., 7, 2016, 106.
49. Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., Pagano, G., Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 37 (2003), 909–916.
50. Newman, J.C., Verdin, E., β-hydroxybutyrate: much more than a metabolite. Diabetes Res. Clin. Pract. 106 (2014), 173–181.
51. Newman, J.C., Verdin, E., β-hydroxybutyrate: a signaling metabolite. Annu. Rev. Nutr. 37 (2017), 51–76.
52. Padmanabhan, S., Joe, B., Towards precision medicine for hypertension: a review of genomic, epigenomic, and microbiomic effects on blood pressure in experimental rat models and humans. Physiol. Rev. 97 (2017), 1469–1528.
53. Paragas, N., Qiu, A., Zhang, Q., Samstein, B., Deng, S.X., Schmidt-Ott, K.M., Viltard, M., Yu, W., Forster, C.S., Gong, G., et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med. 17 (2011), 216–222.
54. Puchalska, P., Crawford, P.A., Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics. Cell Metab. 25 (2017), 262–284.
55. Rapp, J.P., Dene, H., Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats. Hypertension 7 (1985), 340–349.
56. Rapp, J.P., Knudsen, K.D., Iwai, J., Dahl, L.K., Genetic control of blood pressure and corticosteroid production in rats. Circ. Res. 32:Suppl 1 (1973), 139–149.
57. Ringseis, R., Eder, K., Mooren, F.C., Krüger, K., Metabolic signals and innate immune activation in obesity and exercise. Exerc. Immunol. Rev. 21 (2015), 58–68.
58. Roberts, M.N., Wallace, M.A., Tomilov, A.A., Zhou, Z., Marcotte, G.R., Tran, D., Perez, G., Gutierrez-Casado, E., Koike, S., Knotts, T.A., et al. A ketogenic diet extends longevity and healthspan in adult mice. Cell Metab. 26 (2017), 539–546.
59. Rossi, R., Dörig, S., Del Prete, E., Scharrer, E., Suppression of feed intake after parenteral administration of D-beta-hydroxybutyrate in pygmy goats. J. Vet. Med. A Physiol. Pathol. Clin. Med. 47 (2000), 9–16.
60. Rudemiller, N., Lund, H., Jacob, H.J., Geurts, A.M., Mattson, D.L., PhysGen Knockout Program. CD247 modulates blood pressure by altering T-lymphocyte infiltration in the kidney. Hypertension 63 (2014), 559–564.
61. Santacruz, A., Collado, M.C., García-Valdés, L., Segura, M.T., Martín-Lagos, J.A., Anjos, T., Martí-Romero, M., Lopez, R.M., Florido, J., Campoy, C., Sanz, Y., Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br. J. Nutr. 104 (2010), 83–92.
62. Savage, C.D., Lopez-Castejon, G., Denes, A., Brough, D., NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front. Immunol., 3, 2012, 288.
63. Schneeberger, M., Everard, A., Gómez-Valadés, A.G., Matamoros, S., Ramírez, S., Delzenne, N.M., Gomis, R., Claret, M., Cani, P.D., Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci. Rep., 5, 2015, 16643.
64. Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W.S., Huttenhower, C., Metagenomic biomarker discovery and explanation. Genome Biol., 12, 2011, R60.
65. Sepehri, Z., Kiani, Z., Afshari, M., Kohan, F., Dalvand, A., Ghavami, S., Inflammasomes and type 2 diabetes: An updated systematic review. Immunol. Lett. 192 (2017), 97–103.
66. Stienstra, R., van Diepen, J.A., Tack, C.J., Zaki, M.H., van de Veerdonk, F.L., Perera, D., Neale, G.A., Hooiveld, G.J., Hijmans, A., Vroegrijk, I., et al. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 108 (2011), 15324–15329.
67. Sutton, E.F., Beyl, R., Early, K.S., Cefalu, W.T., Ravussin, E., Peterson, C.M., Early time-restricted feeding improves insulin sensitivity, blood pressure, and oxidative stress even without weight loss in men with prediabetes. Cell Metab. 27 (2018), 1212–1221.
68. Theriot, C.M., Koenigsknecht, M.J., Carlson, P.E. Jr., Hatton, G.E., Nelson, A.M., Li, B., Huffnagle, G.B., Z Li, J., Young, V.B., Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat. Commun., 5, 2014, 3114.
69. Tian, N., Moore, R.S., Braddy, S., Rose, R.A., Gu, J.W., Hughson, M.D., Manning, R.D. Jr., Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H3388–H3395.
70. Uetake, Y., Ikeda, H., Irie, R., Tejima, K., Matsui, H., Ogura, S., Wang, H., Mu, S., Hirohama, D., Ando, K., et al. High-salt in addition to high-fat diet may enhance inflammation and fibrosis in liver steatosis induced by oxidative stress and dyslipidemia in mice. Lipids Health Dis., 14, 2015, 6.
71. Vandanmagsar, B., Youm, Y.H., Ravussin, A., Galgani, J.E., Stadler, K., Mynatt, R.L., Ravussin, E., Stephens, J.M., Dixit, V.D., The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17 (2011), 179–188.
72. Veech, R.L., Bradshaw, P.C., Clarke, K., Curtis, W., Pawlosky, R., King, M.T., Ketone bodies mimic the life span extending properties of caloric restriction. IUBMB Life 69 (2017), 305–314.
73. Vilaysane, A., Chun, J., Seamone, M.E., Wang, W., Chin, R., Hirota, S., Li, Y., Clark, S.A., Tschopp, J., Trpkov, K., et al. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J. Am. Soc. Nephrol. 21 (2010), 1732–1744.
74. Wan, Z., Wen, W., Ren, K., Zhou, D., Liu, J., Wu, Y., Zhou, J., Mu, J., Yuan, Z., Involvement of NLRP3 inflammasome in the impacts of sodium and potassium on insulin resistance in normotensive Asians. Br. J. Nutr. 119 (2018), 228–237.
75. Wang, G., Yeung, C.K., Wong, W.Y., Zhang, N., Wei, Y.F., Zhang, J.L., Yan, Y., Wong, C.Y., Tang, J.J., Chuai, M., et al. Liver fibrosis can be induced by high salt intake through excess reactive oxygen species (ROS) production. J. Agric. Food Chem. 64 (2016), 1610–1617.
76. Wang, Y., Xu, Y., Sheng, H., Ni, X., Lu, J., Exercise amelioration of depression-like behavior in OVX mice is associated with suppression of NLRP3 inflammasome activation in hippocampus. Behav. Brain Res. 307 (2016), 18–24.
77. Wang, X., Liu, Q., Zhou, J., Wu, X., Zhu, Q., β hydroxybutyrate levels in serum and cerebrospinal fluid under ketone body metabolism in rats. Exp. Anim. 66 (2017), 177–182.
78. H17 axis and disease. Nature 551 (2017), 585–589.
79. Willner, I.R., Waters, B., Patil, S.R., Reuben, A., Morelli, J., Riely, C.A., Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am. J. Gastroenterol. 96 (2001), 2957–2961.
80. World Health Organization. Diet, nutrition and the prevention of chronic diseases. WHO Tech. Rep. Ser. 916 (2003), 1–149.
81. Wu, C., Yosef, N., Thalhamer, T., Zhu, C., Xiao, S., Kishi, Y., Regev, A., Kuchroo, V.K., Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 496 (2013), 513–517.
82. Xia, J., Psychogios, N., Young, N., Wishart, D.S., MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res., 37, 2009 W652-60.
83. Youm, Y.H., Nguyen, K.Y., Grant, R.W., Goldberg, E.L., Bodogai, M., Kim, D., D'Agostino, D., Planavsky, N., Lupfer, C., Kanneganti, T.D., et al. The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. Nat. Med. 21 (2015), 263–269.
84. Yu, J., Nagasu, H., Murakami, T., Hoang, H., Broderick, L., Hoffman, H.M., Horng, T., Inflammasome activation leads to Caspase-1-dependent mitochondrial damage and block of mitophagy. Proc. Natl. Acad. Sci. USA 111 (2014), 15514–15519.
85. Zhu, Q., Li, X.X., Wang, W., Hu, J., Li, P.L., Conley, S., Li, N., Mesenchymal stem cell transplantation inhibited high salt-induced activation of the NLRP3 inflammasome in the renal medulla in Dahl S rats. Am. J. Physiol. Renal Physiol. 310 (2016), F621–F627.
86. Ziegler, T.R., Luo, M., Estívariz, C.F., Moore, D.A. 3rd, Sitaraman, S.V., Hao, L., Bazargan, N., Klapproth, J.M., Tian, J., Galloway, J.R., et al. Detectable serum flagellin and lipopolysaccharide and upregulated anti-flagellin and lipopolysaccharide immunoglobulins in human short bowel syndrome. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294 (2008), R402–R410.